143 related articles for article (PubMed ID: 26023733)
1. CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma.
Sun L; Bai L; Lin G; Wang R; Liu Y; Cai J; Guo Y; Zhu Z; Xie C
Oncotarget; 2015 Aug; 6(24):20685-96. PubMed ID: 26023733
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway.
Hou C; Sun B; Jiang Y; Zheng J; Yang N; Ji C; Liang Z; Shi J; Zhang R; Liu Y; Ye C; Zuo P
Anticancer Agents Med Chem; 2016; 16(4):501-18. PubMed ID: 26299665
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
[TBL] [Abstract][Full Text] [Related]
4.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
5. IL-10 promotes tumor aggressiveness via upregulation of CIP2A transcription in lung adenocarcinoma.
Sung WW; Wang YC; Lin PL; Cheng YW; Chen CY; Wu TC; Lee H
Clin Cancer Res; 2013 Aug; 19(15):4092-103. PubMed ID: 23743567
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
Zheng Y; Wang R; Song HZ; Pan BZ; Zhang YW; Chen LB
Int J Biochem Cell Biol; 2013 Nov; 45(11):2369-78. PubMed ID: 23892093
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.
Qu X; Zhao B; Hu M; Ji Z; Xu J; Xia W; Qu Y
Med Sci Monit; 2018 Jun; 24():3987-3996. PubMed ID: 29893377
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor interactor 13 (TRIP13) overexpression associated with tumor progression and poor prognosis in lung adenocarcinoma.
Li W; Zhang G; Li X; Wang X; Li Q; Hong L; Shen Y; Zhao C; Gong X; Chen Y; Zhou J
Biochem Biophys Res Commun; 2018 May; 499(3):416-424. PubMed ID: 29567476
[TBL] [Abstract][Full Text] [Related]
9. BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas.
Dai M; Lu JJ; Guo W; Yu W; Wang Q; Tang R; Tang Z; Xiao Y; Li Z; Sun W; Sun X; Qin Y; Huang W; Deng WG; Wu T
Oncotarget; 2015 Oct; 6(32):33878-92. PubMed ID: 26418899
[TBL] [Abstract][Full Text] [Related]
10. Fungal Immunomodulatory Protein from
Xie Y; Li S; Sun L; Liu S; Wang F; Wen B; Sun L; Fang X; Chai Y; Cao H; Jia N; Gu T; Lou X; Xin F
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30388826
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
12. Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells.
Kim HIe; Lee HS; Kim TH; Lee JS; Lee ST; Lee SJ
Oncotarget; 2015 Dec; 6(40):42905-22. PubMed ID: 26556867
[TBL] [Abstract][Full Text] [Related]
13. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
Guo T; Zhao S; Wang P; Xue X; Zhang Y; Yang M; Li N; Li Z; Xu L; Jiang L; Zhao L; Ma PC; Rosell R; Li J; Gu C
Oncotarget; 2017 Jul; 8(29):48110-48125. PubMed ID: 28624808
[TBL] [Abstract][Full Text] [Related]
14. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
Zeng J; Yang X; Yang L; Li W; Zheng Y
Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
[TBL] [Abstract][Full Text] [Related]
15. MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.
He Y; Wang L; Liu W; Zhong J; Bai S; Wang Z; Thomas DG; Lin J; Reddy RM; Ramnath N; Carrott PW; Lynch WR; Orringer MB; Chang AC; Beer DG; Chen G
Sci Rep; 2015 Jun; 5():11471. PubMed ID: 26088427
[TBL] [Abstract][Full Text] [Related]
16. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
[TBL] [Abstract][Full Text] [Related]
17. YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.
Zhao S; Wang Y; Guo T; Yu W; Li J; Tang Z; Yu Z; Zhao L; Zhang Y; Wang Z; Wang P; Li Y; Li F; Sun Z; Xuan Y; Tang R; Deng WG; Guo W; Gu C
Oncotarget; 2016 Dec; 7(50):82139-82157. PubMed ID: 27384875
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Buzhong Yiqi decoction on PI3K and AKT in spleen, stomach and lung of nude mice with lung adenocarcinoma transplantation tumor].
Liu YL; Wang Y; Yi JL; Jing H; Liu CY
Zhongguo Zhong Yao Za Zhi; 2014 May; 39(10):1869-73. PubMed ID: 25282897
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
[TBL] [Abstract][Full Text] [Related]
20. Reduced CENPU expression inhibits lung adenocarcinoma cell proliferation and migration through PI3K/AKT signaling.
Li J; Wang ZG; Pang LB; Zhang RH; Wang YY
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1077-1084. PubMed ID: 30849291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]